111 lines
6.7 KiB
JSON
111 lines
6.7 KiB
JSON
{
|
|
"date": "2026-03-08",
|
|
"llm_provider": "google",
|
|
"recommendations": [
|
|
{
|
|
"ticker": "ZVRA",
|
|
"rank": 1,
|
|
"company_name": "Zevra Therapeutics, Inc.",
|
|
"description": "Zevra Therapeutics is a commercial-stage pharmaceutical company focusing on rare disease treatments using its Ligand Activated Technology platform.",
|
|
"strategy_match": "earnings_play",
|
|
"pipeline": "earnings_play",
|
|
"final_score": 88,
|
|
"confidence": 9,
|
|
"risk_level": "speculative",
|
|
"reason": "This is a high-conviction pre-earnings setup driven by unusually aggressive bullish options positioning, with a Put/Call ratio of just 0.059. Short interest is elevated at 8.9%, creating a potential squeeze setup if earnings surprise to the upside tomorrow (March 9). The stock is technically holding its 50 SMA support with a recent bullish MACD crossover, signaling momentum alignment. The convergence of 'smart money' call flow and short squeeze potential makes this a timely, albeit binary, opportunity.",
|
|
"entry_price": 8.979999542236328,
|
|
"discovery_date": "2026-03-08",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "KKR",
|
|
"rank": 2,
|
|
"company_name": "KKR & Co. Inc.",
|
|
"description": "KKR is a leading global investment firm managing assets across private equity, energy, infrastructure, real estate, and credit strategies.",
|
|
"strategy_match": "insider_buying",
|
|
"pipeline": "insider_buying",
|
|
"final_score": 85,
|
|
"confidence": 9,
|
|
"risk_level": "moderate",
|
|
"reason": "Co-CEOs Scott Nuttall and Joseph Bae heavily accumulated shares recently, with purchases totaling over $25 million in late February. The stock is currently oversold (RSI 36) and trading significantly below the 50 SMA, offering a mean-reversion opportunity backed by the highest tier of insider conviction. While the trend is currently down, the magnitude of executive buying serves as a strong floor and signal of undervalued fundamentals. A bullish MACD crossover is beginning to form, suggesting momentum may be shifting.",
|
|
"entry_price": 91.33000183105469,
|
|
"discovery_date": "2026-03-08",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "CSX",
|
|
"rank": 3,
|
|
"company_name": "CSX Corporation",
|
|
"description": "CSX Corporation is a major transportation company providing rail-based freight services across the eastern United States.",
|
|
"strategy_match": "insider_buying",
|
|
"pipeline": "insider_buying",
|
|
"final_score": 82,
|
|
"confidence": 8,
|
|
"risk_level": "low",
|
|
"reason": "CEO Stephen Angel purchased over $1 million in stock, coinciding with highly bullish options flow (Put/Call ratio of 0.134). The stock is trading near its lower Bollinger Band in a broader uptrend, presenting a classic 'buy the dip' technical setup supported by executive skin in the game. With the price holding near the 50 SMA and analysts maintaining a 76% bullish sentiment, the risk/reward is favorable for a short-term bounce.",
|
|
"entry_price": 39.95000076293945,
|
|
"discovery_date": "2026-03-08",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "WGS",
|
|
"rank": 4,
|
|
"company_name": "GeneDx Holdings Corp.",
|
|
"description": "GeneDx Holdings provides genomic testing and diagnostic services, specializing in rare disease and pediatric genetics.",
|
|
"strategy_match": "insider_buying",
|
|
"pipeline": "insider_buying",
|
|
"final_score": 78,
|
|
"confidence": 7,
|
|
"risk_level": "high",
|
|
"reason": "Activist investor Keith Meister (Director/10% owner) purchased over $13.4 million in shares, a massive vote of confidence that outweighs recent selling by other executives. The stock has strong momentum (+18% in 5 days) and high short interest (25.6%), creating conditions for a continued squeeze. Technicals show a bullish MACD crossover and price holding above the 20 EMA, confirming the immediate trend is upward despite high volatility.",
|
|
"entry_price": 88.11000061035156,
|
|
"discovery_date": "2026-03-08",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "ABTC",
|
|
"rank": 5,
|
|
"company_name": "American Bitcoin Corp.",
|
|
"description": "American Bitcoin Corp. focuses on Bitcoin infrastructure and accumulation strategies, operating as a subsidiary of Hut 8 Corp.",
|
|
"strategy_match": "insider_buying",
|
|
"pipeline": "insider_buying",
|
|
"final_score": 75,
|
|
"confidence": 7,
|
|
"risk_level": "speculative",
|
|
"reason": "Multiple insiders, including a Director, have purchased over $2.1 million in shares, a massive figure relative to the company's $1B market cap and low share price. This insider cluster buying is supported by bullish options flow (P/C ratio 0.226). While the stock is in a downtrend, this level of insider accumulation often precedes a sharp reversal or news catalyst. The trade is speculative given the sector's volatility but has high upside potential.",
|
|
"entry_price": 1.090000033378601,
|
|
"discovery_date": "2026-03-08",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "CSCO",
|
|
"rank": 6,
|
|
"company_name": "Cisco Systems, Inc.",
|
|
"description": "Cisco Systems is a worldwide leader in networking hardware, software, and telecommunications equipment.",
|
|
"strategy_match": "analyst_upgrade",
|
|
"pipeline": "analyst_upgrade",
|
|
"final_score": 72,
|
|
"confidence": 7,
|
|
"risk_level": "low",
|
|
"reason": "Institutional accumulation is evident with a recent analyst upgrade and unusual bullish options activity (Put/Call ratio 0.522). The stock remains in a strong long-term uptrend (above 200 SMA) despite recent consolidation. With low volatility compared to other tech names, CSCO offers a stable entry point for a reversion trade back toward its recent highs.",
|
|
"entry_price": 78.63999938964844,
|
|
"discovery_date": "2026-03-08",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "NMFC",
|
|
"rank": 7,
|
|
"company_name": "New Mountain Finance Corporation",
|
|
"description": "New Mountain Finance Corporation is a business development company focusing on direct lending to middle-market companies.",
|
|
"strategy_match": "insider_buying",
|
|
"pipeline": "insider_buying",
|
|
"final_score": 68,
|
|
"confidence": 6,
|
|
"risk_level": "moderate",
|
|
"reason": "A Director recently purchased over $2.5 million in shares, signaling strong support at these price levels. The stock is showing signs of a reversal with a bullish MACD crossover and rising On-Balance Volume (OBV). While the broader trend has been down, the significant yield (16%) and insider protection provide a solid floor for a relief rally.",
|
|
"entry_price": 7.980000019073486,
|
|
"discovery_date": "2026-03-08",
|
|
"status": "open"
|
|
}
|
|
]
|
|
} |